Aditxt Amends Filing with Financials for Ignite Proteomics
Ticker: ADTX · Form: 8-K/A · Filed: 2026-04-07T16:02:58-04:00
Sentiment: neutral
Topics: amendment, financial-statements, pro-forma
TL;DR
Aditxt dropped updated financials for Ignite Proteomics LLC, check it out.
AI Summary
Aditxt, Inc. filed an amendment (8-K/A) on April 7, 2026, to its previous filing. This amendment includes audited financial statements for Ignite Proteomics LLC as of December 31, 2025, and unaudited pro forma consolidated financial information for the year ended December 31, 2025. The filing also contains the consent of CBIZ CPAS, P.C.
Why It Matters
This amendment provides updated financial information related to Ignite Proteomics LLC, which is crucial for investors to assess the company's financial health and the impact of this subsidiary.
Risk Assessment
Risk Level: medium — Amendments to financial statements can indicate previously undisclosed issues or a need for clarification, warranting closer investor scrutiny.
Key Numbers
- December 31, 2025 — Financial Statement Date (Audited financial statements for Ignite Proteomics LLC are as of this date.)
- 2025 — Pro Forma Period (Unaudited pro forma consolidated financial information is for the year ended this year.)
Key Players & Entities
- Aditxt, Inc. (company) — Filer of the amendment
- Ignite Proteomics LLC (company) — Subsidiary whose financial statements are included
- CBIZ CPAS, P.C. (company) — Provided consent included in the filing
- December 31, 2025 (date) — Reporting period for financial statements
- April 7, 2026 (date) — Filing date of the amendment
FAQ
What specific financial details are provided for Ignite Proteomics LLC?
The filing includes audited financial statements for Ignite Proteomics LLC as of December 31, 2025.
What is the purpose of the unaudited pro forma consolidated financial information?
The unaudited pro forma consolidated financial information is provided as of and for the year ended December 31, 2025.
Who provided consent for this filing?
CBIZ CPAS, P.C. provided their consent, which is included as an exhibit.
Is this a new filing or an amendment?
This is an amendment (8-K/A) to a previous filing.
What is the filing date of this amendment?
The amendment was filed on April 7, 2026.
From the Filing
EDGAR Filing Documents for 0001213900-26-041018 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K/A - Current report: [Amend] SEC Accession No. 0001213900-26-041018 Filing Date 2026-04-07 Accepted 2026-04-07 16:02:58 Documents 18 Period of Report 2026-03-10 Items Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 AMENDMENT NO. 1 TO FORM 8-K ea0285319-8ka1_aditxt.htm iXBRL 8-K/A 31005 2 CONSENT OF CBIZ CPAS P.C ea028531901ex23-1.htm EX-23.1 2406 3 AUDITED FINANCIAL STATEMENTS OF IGNITE PROTEOMICS LLC AS OF DECEMBER 31, 2025 AN ea028531901ex99-1.htm EX-99.1 141047 4 UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL INFORMATION AS OF AND FOR THE YEAR EN ea028531901ex99-2.htm EX-99.2 160834 5 UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL INFORMATION AS OF AND FOR THE YEAR EN ea028531901ex99-3.htm EX-99.3 167957 6 GRAPHIC ea028531901_ex23-1img1.jpg GRAPHIC 15198 7 GRAPHIC ea028531901_ex23-1img2.jpg GRAPHIC 13795 8 GRAPHIC ea028531901_ex99-1img1.jpg GRAPHIC 12686 Complete submission text file 0001213900-26-041018.txt 783669 Data Files Seq Description Document Type Size 9 XBRL SCHEMA FILE adtx-20260310.xsd EX-101.SCH 3008 10 XBRL LABEL FILE adtx-20260310_lab.xml EX-101.LAB 34239 11 XBRL PRESENTATION FILE adtx-20260310_pre.xml EX-101.PRE 22354 21 EXTRACTED XBRL INSTANCE DOCUMENT ea0285319-8ka1_aditxt_htm.xml XML 4188 Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844 Aditxt, Inc. (Filer) CIK : 0001726711 (see all company filings) EIN. : 823204328 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K/A | Act: 34 | File No.: 001-39336 | Film No.: 26844693 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)